Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review
- PMID: 37174152
- PMCID: PMC10177939
- DOI: 10.3390/ijerph20095633
Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review
Abstract
Clinical and economic burdens exist within the coronary artery disease (CAD) care pathway despite advances in diagnosis and treatment and the increasing utilization of percutaneous coronary intervention (PCI). However, research presenting a comprehensive assessment of the challenges across this pathway is scarce. This contemporary review identifies relevant studies related to inefficiencies in the diagnosis, treatment, and management of CAD, including clinician, patient, and economic burdens. Studies demonstrating the benefits of integration and automation within the catheterization laboratory and across the CAD care pathway were also included. Most studies were published in the last 5-10 years and focused on North America and Europe. The review demonstrated multiple potentially avoidable inefficiencies, with a focus on access, appropriate use, conduct, and follow-up related to PCI. Inefficiencies included misdiagnosis, delays in emergency care, suboptimal testing, longer procedure times, risk of recurrent cardiac events, incomplete treatment, and challenges accessing and adhering to post-acute care. Across the CAD pathway, this review revealed that high clinician burnout, complex technologies, radiation, and contrast media exposure, amongst others, negatively impact workflow and patient care. Potential solutions include greater integration and interoperability between technologies and systems, improved standardization, and increased automation to reduce burdens in CAD and improve patient outcomes.
Keywords: automation; burdens; coronary artery disease; diagnostic imaging; echocardiography; inefficiencies; integration; myocardial ischemia; percutaneous coronary intervention; treatment.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Pearl Vyas, Inge Jenniskens, Sara Chen, and Ramon Julian Pesigan are employees of Philips. Jennifer Franke is an employee of Philips GmbH. Nicole Ferko, Barkha P. Patel, Annamaria Dobrin, and Jayson Habib are employees of CRG-EVERSANA Canada Inc., which received funding from Philips (The Netherlands) to conduct this analysis.
Figures
References
-
- Khan M.A., Hashim M.J., Mustafa H., Baniyas M.Y., Al Suwaidi S., AlKatheeri R., Alblooshi F.M.K., Almatrooshi M., Alzaabi M.E.H., Al Darmaki R.S., et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12:e9349. doi: 10.7759/cureus.9349. - DOI - PMC - PubMed
-
- Tsao C.W., Aday A.W., Almarzooq Z.I., Anderson C.A.M., Arora P., Avery C.L., Baker-Smith C.M., Beaton A.Z., Boehme A.K., Buxton A.E., et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93–e621. doi: 10.1161/CIR.0000000000001123. - DOI - PubMed
-
- Institute for Health Metrics and Evaluation Global Burden of Disease (GBD) Results Tool. 2019. [(accessed on 20 July 2022)]. Available online: https://ghdx.healthdata.org/gbd-results-tool.
-
- Dai H., Much A.A., Maor E., Asher E., Younis A., Xu Y., Lu Y., Liu X., Shu J., Bragazzi N.L. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: Results from the Global Burden of Disease Study 2017. Eur. Heart J. Qual. Care Clin. Outcomes. 2022;8:50–60. doi: 10.1093/ehjqcco/qcaa076. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
